RedHill Biopharma (RDHL) Property, Plant & Equipment (Net) (2011 - 2025)

RedHill Biopharma (RDHL) Property, Plant & Equipment (Net) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 37.35 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 4.00 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 3.72 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 13.52 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 1.84 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 49,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 2.53 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 90.90 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.40 Bn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 232.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 49,000.00
Dec 31, 2025 49,000.00
Jun 30, 2025 126,000.00
Jun 30, 2025 126,000.00
Dec 31, 2024 135,000.00
Dec 31, 2024 135,000.00
Jun 30, 2024 147,000.00
Jun 30, 2024 147,000.00
Dec 31, 2023 193,000.00
Dec 31, 2023 193,000.00
Jun 30, 2023 244,000.00
Jun 30, 2023 244,000.00
Mar 31, 2023 444,000.00
Mar 31, 2023 444,000.00
Dec 31, 2022 502,000.00
Dec 31, 2022 502,000.00
Sep 30, 2022 568,000.00
Sep 30, 2022 568,000.00
Jun 30, 2022 616,000.00
Jun 30, 2022 616,000.00